Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 11 | 2024 | 81 | 3.070 |
Why?
|
| Lymphatic Abnormalities | 5 | 2022 | 35 | 2.470 |
Why?
|
| Hemangioma | 8 | 2024 | 94 | 2.300 |
Why?
|
| Sirolimus | 9 | 2024 | 220 | 1.730 |
Why?
|
| Hemangioendothelioma | 4 | 2020 | 25 | 1.460 |
Why?
|
| Kasabach-Merritt Syndrome | 3 | 2020 | 16 | 1.300 |
Why?
|
| Sarcoma, Kaposi | 3 | 2020 | 120 | 1.180 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2021 | 127 | 0.970 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2024 | 7 | 0.960 |
Why?
|
| Lymphangioma | 2 | 2021 | 22 | 0.920 |
Why?
|
| Chylothorax | 2 | 2021 | 26 | 0.920 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 38 | 0.840 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2023 | 50 | 0.830 |
Why?
|
| Osteolysis, Essential | 1 | 2021 | 5 | 0.750 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2021 | 15 | 0.750 |
Why?
|
| Pleural Effusion | 1 | 2021 | 100 | 0.730 |
Why?
|
| Vascular Neoplasms | 1 | 2020 | 32 | 0.700 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 1259 | 0.670 |
Why?
|
| Arteriovenous Malformations | 3 | 2024 | 46 | 0.630 |
Why?
|
| Embolization, Therapeutic | 3 | 2024 | 226 | 0.520 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 31 | 0.480 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 802 | 0.450 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 1305 | 0.440 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2023 | 8 | 0.420 |
Why?
|
| Child | 20 | 2024 | 24208 | 0.380 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2011 | 19 | 0.370 |
Why?
|
| Lymphatic Vessels | 2 | 2021 | 37 | 0.360 |
Why?
|
| Upper Extremity | 1 | 2011 | 53 | 0.360 |
Why?
|
| Blood Vessels | 1 | 2010 | 104 | 0.340 |
Why?
|
| Humans | 40 | 2024 | 123190 | 0.330 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 76 | 0.330 |
Why?
|
| Infant | 14 | 2024 | 12323 | 0.330 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 172 | 0.320 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 211 | 0.320 |
Why?
|
| Consensus | 2 | 2024 | 612 | 0.310 |
Why?
|
| Infant, Newborn | 10 | 2024 | 8089 | 0.310 |
Why?
|
| Thrombocytopenia | 2 | 2021 | 229 | 0.300 |
Why?
|
| Drainage | 2 | 2021 | 254 | 0.300 |
Why?
|
| Neutropenia | 2 | 2020 | 202 | 0.290 |
Why?
|
| Ascites | 2 | 2018 | 87 | 0.290 |
Why?
|
| Congenital Abnormalities | 1 | 2010 | 246 | 0.290 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 240 | 0.270 |
Why?
|
| Epistaxis | 1 | 2024 | 12 | 0.240 |
Why?
|
| Lymphatic System | 2 | 2021 | 20 | 0.230 |
Why?
|
| Purpura | 1 | 2023 | 24 | 0.220 |
Why?
|
| Arteriovenous Fistula | 1 | 2023 | 56 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 200 | 0.210 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2022 | 28 | 0.210 |
Why?
|
| Octreotide | 1 | 2021 | 21 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 73 | 0.200 |
Why?
|
| Lymphedema | 1 | 2021 | 19 | 0.190 |
Why?
|
| Otolaryngology | 1 | 2023 | 104 | 0.190 |
Why?
|
| Angiomatosis | 1 | 2021 | 6 | 0.190 |
Why?
|
| Retrospective Studies | 10 | 2023 | 15979 | 0.190 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 31 | 0.180 |
Why?
|
| Rhabdomyoma | 1 | 2021 | 16 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2022 | 163 | 0.180 |
Why?
|
| Hemangioma, Capillary | 1 | 2020 | 17 | 0.170 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2020 | 39 | 0.170 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 101 | 0.170 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 45 | 0.170 |
Why?
|
| Accelerated Idioventricular Rhythm | 1 | 2019 | 1 | 0.170 |
Why?
|
| Ethiodized Oil | 1 | 2019 | 2 | 0.170 |
Why?
|
| Child, Preschool | 7 | 2023 | 13862 | 0.160 |
Why?
|
| Muscle Weakness | 1 | 2020 | 83 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 80 | 0.160 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2019 | 17 | 0.160 |
Why?
|
| Thrombosis | 1 | 2023 | 520 | 0.160 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 580 | 0.160 |
Why?
|
| Male | 15 | 2022 | 60020 | 0.150 |
Why?
|
| Peritoneovenous Shunt | 1 | 2018 | 5 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 151 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 269 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2024 | 997 | 0.150 |
Why?
|
| Chylous Ascites | 1 | 2017 | 11 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 197 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 197 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 272 | 0.140 |
Why?
|
| Prognosis | 4 | 2020 | 4508 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 906 | 0.140 |
Why?
|
| Critical Illness | 1 | 2021 | 595 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2018 | 213 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 645 | 0.140 |
Why?
|
| Thrombocytosis | 1 | 2017 | 34 | 0.140 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 98 | 0.140 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1528 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 193 | 0.130 |
Why?
|
| Female | 12 | 2023 | 65427 | 0.130 |
Why?
|
| Anemia | 1 | 2020 | 339 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 549 | 0.130 |
Why?
|
| Iron Chelating Agents | 1 | 2014 | 14 | 0.120 |
Why?
|
| Iron Overload | 1 | 2014 | 15 | 0.120 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 38 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 113 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2020 | 648 | 0.110 |
Why?
|
| Kidney | 1 | 2020 | 1338 | 0.110 |
Why?
|
| Mutation | 3 | 2022 | 5778 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 790 | 0.100 |
Why?
|
| Young Adult | 3 | 2023 | 8868 | 0.100 |
Why?
|
| Registries | 1 | 2018 | 1390 | 0.100 |
Why?
|
| Lymphoma | 1 | 2014 | 322 | 0.090 |
Why?
|
| Leukemia | 1 | 2014 | 376 | 0.090 |
Why?
|
| Radiology, Interventional | 2 | 2022 | 28 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2022 | 3007 | 0.090 |
Why?
|
| Pregnancy | 1 | 2023 | 7124 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3518 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2010 | 55 | 0.090 |
Why?
|
| Adolescent | 7 | 2022 | 19086 | 0.090 |
Why?
|
| Pediatrics | 1 | 2018 | 1139 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2011 | 671 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 191 | 0.070 |
Why?
|
| United States | 2 | 2023 | 10618 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2007 | 29 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2007 | 38 | 0.070 |
Why?
|
| Connexins | 1 | 2007 | 59 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2023 | 12102 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2023 | 1871 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 4225 | 0.070 |
Why?
|
| Adult | 3 | 2022 | 29035 | 0.060 |
Why?
|
| Lumbosacral Region | 1 | 2024 | 33 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 522 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2023 | 101 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1597 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2022 | 5 | 0.050 |
Why?
|
| Propranolol | 1 | 2023 | 128 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2022 | 30 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2308 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1916 | 0.050 |
Why?
|
| Sclerotherapy | 1 | 2022 | 40 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 208 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2023 | 234 | 0.050 |
Why?
|
| Urogenital Abnormalities | 1 | 2024 | 168 | 0.050 |
Why?
|
| Syndrome | 1 | 2024 | 1114 | 0.050 |
Why?
|
| Endothelium, Lymphatic | 1 | 2021 | 10 | 0.050 |
Why?
|
| Oseltamivir | 1 | 2020 | 16 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 353 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2020 | 39 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 100 | 0.040 |
Why?
|
| Vomiting | 1 | 2020 | 115 | 0.040 |
Why?
|
| Fatigue | 1 | 2020 | 217 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 780 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5047 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 965 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2018 | 89 | 0.040 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 123 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2010 | 4508 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 1861 | 0.040 |
Why?
|
| Peritoneum | 1 | 2017 | 36 | 0.040 |
Why?
|
| Fever | 1 | 2020 | 296 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2019 | 220 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2017 | 42 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 151 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 197 | 0.030 |
Why?
|
| Chelation Therapy | 1 | 2014 | 3 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 740 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2801 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3377 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 469 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2548 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 236 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3662 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1931 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1480 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6028 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2947 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 33740 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3098 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 2838 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1013 | 0.020 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2007 | 8 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 17 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 370 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 611 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 467 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 10001 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3288 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 17497 | 0.010 |
Why?
|